Calcik

Quick links to important sections

Calcik

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calcik

What is Calcik? Overview and Quick Facts

The following information defines the nature, composition, and general purpose of Calcik, focusing strictly on its identity as a mineral supplement.

Property Description
Active Ingredient Calcium Citrate
Form Oral Tablet, Capsule, or Solution
Pharmacological Class Minerals and Electrolytes (Therapeutic Nutrient)
General Purpose Supplementing dietary calcium intake
Origin Synthetic Organic Salt

Definition, Classification, and Composition

Calcik is an oral mineral supplement that serves as a therapeutic nutrient, classified within the Anatomical Therapeutic Chemical (ATC) classification for Mineral Supplements (A12AA09). It is often positioned as an accessible, over-the-counter choice for consumers. The single active ingredient is Calcium Citrate (tricalcium dicitrate), which is an organic salt formed by combining elemental calcium with citric acid. This structure is recognized for its efficiency in addressing low dietary calcium intake.

Physical Form and General Purpose

Calcik is manufactured for the oral route of administration and is typically found as an oral tablet, capsule, or sometimes a liquid solution, offering flexibility for consistent daily ingestion. The overall purpose of using Calcik is to ensure adequate calcium intake and assist in the maintenance of calcium balance. Calcium is essential not only for bone structure but also for crucial functions like nerve signaling and muscle contraction. A typical use scenario involves adults seeking to maintain bone density as part of their long-term wellness strategy.

Why Calcium Citrate? Understanding the Key Mechanism and Differentiation

The defining characteristic of Calcium Citrate is its absorption profile. The citrate form is generally well-absorbed across the intestinal lining compared to other calcium salts, particularly in individuals with low stomach acid. This mechanism provides a clear point of differentiation, making it a viable option for populations, such as older adults, where stomach acid production may be reduced. By maximizing absorption, Calcik helps ensure a more consistent supply of the necessary mineral for supporting long-term bone integrity and regulatory cell processes.

What side effects are possible with Calcik?

Possible Side Effects and Safety Information

The official safety information for Calcik (Calcium Citrate) is structured by governmental regulatory authorities to categorize and communicate documented risks associated with its use, focusing on both common side effects and rare, serious reactions. These classifications reflect how regulatory documents organize and communicate the medicine's safety profile based on clinical experience.


Adverse Reaction Scope

Category Regulatory Documentation Overview
Common Side Effects Gastrointestinal disturbances are the most frequently documented adverse reactions, including constipation, gas/flatulence, bloating, and upset stomach.
Less Common Reactions Reactions officially classified as less common or rare include hypercalcemia (high calcium levels), nausea, vomiting, diarrhea, and skin reactions like rash.
Serious Safety Concerns High-level risks documented include severe hypercalcemia (which may affect the central nervous system), severe hypersensitivity reactions (allergic response), and the documented potential for nephrolithiasis (kidney stones).

Population-Specific Safety Considerations

Official prescribing information includes constraints for specific user groups. Caution and frequent monitoring of serum calcium are necessary for patients with renal impairment (kidney disease) or a history of kidney stones. The product is formally contraindicated (should not be used) in individuals with pre-existing hypercalcemia (high calcium levels) or a known hypersensitivity to the supplement's components.


The safety profile explicitly requires caution and monitoring for specific populations and defines absolute restrictions for use, as documented in regulatory labeling.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents define the overdose of Calcik (Calcium Citrate) by the resultant physiological state of hypercalcemia (abnormally high blood calcium levels). Documented clinical manifestations of overdose include systemic effects such as nausea, vomiting, unusual weakness, and loss of appetite. Renal and fluid effects are noted, such as increased thirst and increased urination. Neurological signs may involve confusion and irritability.

Overdose carries a risk of potentially severe or life-threatening outcomes. Serious manifestations listed in regulatory information include irregular heartbeat (cardiac dysrhythmias) and progressive central nervous system effects, such as stupor and coma. Patients with diminished renal function are specifically documented as having increased susceptibility to severe hypercalcemia.

Official guidance mandates that the public seek immediate medical attention or contact a poison control center at once if an overdose is suspected. Management is defined as symptomatic and supportive treatment, including the discontinuation of the supplement, administration of intravenous fluids, and close monitoring of vital signs and heart function via an ECG.

Therapeutic Uses of Calcik

What Calcik Treats: Main Uses and Benefits

The therapeutic application of Calcik (Calcium Citrate) is relevant for easing symptoms related to systemic imbalance and supporting the structural integrity of the skeletal system. Supporting adequate calcium intake over a lifetime may play a role in managing conditions associated with low bone density.

The supplement is commonly used to help with prevention and management regimens for conditions like osteoporosis, osteopenia, and systemic calcium deficiency (hypocalcemia). It helps address symptoms related to systemic imbalance by supporting bone structure, thereby reducing the vulnerability to fragility fractures. It also supports the mineral's availability for critical non-skeletal functions, including stable nerve signaling and proper muscle contraction.

“The use of Calcik assists with reliable absorption, which supports general well-being during symptomatic phases.”

In clinical settings where patients have digestive environments that challenge mineral uptake, such as those with low stomach acid or who are are taking acid-blocking medications, the citrate salt may be considered relevant in these contexts. It supports reliable delivery of the mineral for appropriate therapeutic benefit in these unique contexts.


Quick Fact: Relief for Structural Weakness

Calcik assists with maintaining functional stability by providing foundational support to the skeletal system, which helps reduce the overall burden of symptoms associated with low bone density.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia on Calcium Supplements

Eligibility and Restrictions for Use

The eligibility profile for Calcik (Calcium Citrate) is strictly defined by regulatory agencies based on the patient's existing mineral status and organ function.

Populations Who Must Not Use Calcik (Contraindications)

Calcik is absolutely contraindicated in individuals with pre-existing conditions of calcium overload. This includes patients with documented hypercalcemia (elevated blood calcium) and hypercalciuria (high levels of calcium in the urine). The supplement must also be avoided by those with severe renal impairment (kidney failure) and individuals with nephrolithiasis (kidney stones) or nephrocalcinosis, as use risks worsening these conditions.


Restricted and Conditional Use

Use of Calcik requires caution and close monitoring for patients with mild to moderate renal impairment or conditions like sarcoidosis, to prevent mineral imbalances. The medicine is generally not recommended for use during pregnancy unless strictly necessary, and high doses must be avoided. Use during lactation is considered generally safe, with monitoring recommended.


Age-Group Eligibility

Use is officially established and permitted across all age groups, from pediatric to older adult, to meet nutritional requirements. The Calcium Citrate form is often the preferred choice for older adults due to its established superior absorption in low stomach acid conditions.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Calcik (Calcium Citrate) has documented interaction patterns primarily concerning two structural mechanisms: the alteration of co-administered medicine exposure and the pharmacodynamic risk of calcium-level elevation.

Interactions Reducing Other Medicine's Exposure

Co-administration with Calcik may lead to a clinically significant reduction in the systemic absorption of several medicinal products due to chelation (binding) in the digestive tract. These include agents such as Fluoroquinolone and Tetracycline antibiotics, the thyroid hormone Levothyroxine, and Bisphosphonates used for bone conditions. This effect necessitates specific timing separation requirements documented in regulatory labels. For example, Levothyroxine must be administered at least four hours apart from Calcik, and certain antibiotics require a separation of two hours before or six hours after Calcik intake. Furthermore, substances such as Iron and Zinc supplements may also experience reduced absorption.

Interactions Increasing Risk of Calcium Overload

Official documents note pharmacodynamic interactions that increase the risk of hypercalcaemia. Thiazide Diuretics may decrease the excretion of calcium, leading to increased serum levels. Use with Cardiac Glycosides (e.g., Digoxin) requires extreme caution and monitoring due to the documented increase in arrhythmogenic and cardiotoxic activities when calcium levels are elevated. Caution is also specifically warranted in patients with pre-existing cardiac disease or severe renal impairment. An absolute restriction is the contraindication of co-administration with intravenous Ceftriaxone due to precipitation risk.

Mechanism of Action

Dual-Action Mechanism on Bone Turnover

Calcik inhibits the Cathepsin K enzyme, a protease secreted by osteoclasts and a critical biological target in bone metabolism. Calcik binds reversibly to the enzyme's active site via a competitive antagonism mechanism, preventing Cathepsin K from hydrolyzing collagen and other bone matrix proteins. This targeted action is the primary mechanism by which the compound exerts its influence on the skeletal system. The resulting decrease in Cathepsin K activity directly alters the bone remodeling cycle by reducing the rate of osteoclast-mediated bone resorption.


Molecular Influence on Bone Cells

This action shifts the balance of cellular activity, influencing the net equilibrium between osteoblast (bone-forming) and osteoclast (bone-resorbing) function. Furthermore, Calcik also modulates the Wnt/beta-catenin signaling pathway, a cascade critical for promoting the differentiation and activity of osteoblasts, thus influencing bone formation. The combined effect of inhibiting bone resorption (Cathepsin K antagonism) and promoting bone formation (Wnt/beta-catenin modulation) results in an altered net bone turnover rate. This systemic action is described entirely at the physiological level, where the change in bone remodeling equilibrium is reflected by measurable changes in bone matrix deposition and bone structural markers.

Dosage and Administration Information

How to Use Calcik: Official Administration Guidelines

Calcik (Calcium Citrate) is an oral supplement, and its use is governed by principles designed to maximize mineral absorption and ensure adherence to established dietary standards. These guidelines focus strictly on administration.


Administration and Dosing Principles

Category Official Instructions and Principles
Route of Administration The approved route is Oral (ingestion of a tablet, capsule, or solution).
Intake Condition Calcik may be taken with or without food. This provides flexibility in administration and is a key difference from other calcium salts.
Single Dose Limit To optimize absorption, single doses of elemental calcium should generally not exceed 500 mg, necessitating the total daily intake be divided.
Dosing Frequency The total daily requirement is typically administered in divided doses, separated by approximately 4 to 6 hours.

Constraints and Special Instructions

Constraint Official Instruction Details
Total Daily Limit (UL) Total calcium intake from all sources (diet and supplements) must not exceed the Tolerable Upper Intake Level (UL), such as 2,500 mg/day.
Drug Separation Administration of Calcik must be separated from certain other oral medications, such as specific antibiotics or thyroid hormones, by at least 2 to 6 hours to prevent interference with their uptake.
Form Preparation If using an effervescent form, the tablet must be fully dissolved in water before ingestion.

These instructions define the standardized approach for using the medicine. They specify the proper route and preparation of the dosage form, guide users on appropriate dose splitting for absorption, and mandate essential timing separation from other medications to ensure proper procedural use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Calcik

Research Evidence for Bone Mineral Density (BMD)

Research has explored the role of Calcik (Calcium Citrate) in studies involving individuals needing mineral supplementation, primarily for bone health. The majority of the evidence comes from randomized controlled trials (RCTs) and comprehensive meta-analyses. These studies were primarily applied in research contexts involving postmenopausal women and older adults with low calcium intake. Researchers monitored Bone Mineral Density (BMD) at the hip and spine, along with biochemical bone turnover markers.

Studies monitored how these measurements evolved, typically over one to two-and-a-half years. Findings describe patterns where a small, non-progressive change in BMD was measured. This change often occurred early in the trial. While these findings contribute to the broader evidence landscape, BMD is an indirect measure. Data remains insufficient regarding whether these small measured changes directly translate to a major, observable outcome, such as long-term fracture risk.

Evidence Landscape for Fragility Fracture Risk

Long-term randomized controlled trials have been was studied for directly examining the impact of calcium supplementation on outcomes related to fracture incidence. Research describes that when analyzing the full body of evidence, the findings were mixed regarding whether a consistent reduction in fracture incidence was observed across all community-dwelling older adults. In some studies, particularly those involving institutionalized elderly, patterns related to fracture incidence were observed in some studies to differ from placebo.

A key research limitation is that many influential long-term trials was associated with the co-administration of Vitamin D alongside calcium. Because of this, it is challenging to separate and characterize the data for Calcik used without Vitamin D. Evidence quality varies across studies, and comparative evidence is lacking from trials specifically focused on the long-term, single-agent effect.

Studies on Absorption and Bioavailability of Calcium Citrate

Research has extensively was evaluated in how the specific citrate form of calcium is absorbed by the body. These short-term pharmacokinetic studies and crossover RCTs focused on measuring blood calcium levels after ingestion. Studies consistently reported measurements indicating a higher relative absorption profile for the citrate salt form, particularly when taken in environments with reduced stomach acid. Reported differences in absorption are documented in the scientific literature. Study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Calcium intake and bone mineral density: systematic review and meta-analysis
  2. Hypocalcemia: Diagnosis and Treatment - Endotext (Used for context on specific patient populations)
  3. Efficacy of Calcium Citrate Versus Calcium Carbonate for the Management of Chronic Hypoparathyroidism (Clinical Trial NCT03425747 - Used for context on specific patient contexts)

Frequently Asked Questions (FAQ)

Common questions about Calcik (FAQ)

Q: If I miss a dose of Calcik, what is the usual recommendation?

Official patient information states that the standard instruction for a missed dose is to take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Regulatory documents describe that extra medicine should not be taken to compensate for a missed dose.


Q: Are there any specific warning signs of a serious reaction to Calcik?

Official safety information lists specific warning signs related to serious conditions. These include signs of a severe allergic reaction, such as swelling of the face, difficulty breathing, or hives. Signs of high blood calcium (hypercalcemia) may also include confusion, muscle weakness, or significantly increased thirst and urination. Official safety documents describe the importance of monitoring for these signs.


Q: Can Calcik be taken with multivitamins?

Official warnings describe the need to consult a healthcare professional before taking multivitamins or other mineral supplements alongside Calcik. This is because Calcik can reduce the absorption of certain co-administered minerals like Iron and Zinc, which are commonly found in multivitamins. Separation of doses is a factor that is often considered to minimize this effect.


Q: Does Calcik interact with antacids or medicines for heartburn?

Calcik is known to interact with antacids that contain aluminum, as its citrate component can increase the body's absorption of aluminum. Regulatory labels describe the requirement to separate the doses of these products by 2 to 3 hours to prevent interaction. The need for separation is particularly noted for individuals with reduced kidney function.


Q: Why does the packaging of Calcik mention a need for Vitamin D?

Studies and official information indicate that Vitamin D is essential for the body to absorb calcium through the gut and is required for maintaining proper calcium levels in the blood. For this reason, calcium and Vitamin D are often given together in research studies and combination products aimed at supporting bone health.


Q: How does Calcik affect lab tests or medical screenings?

The use of Calcik (Calcium Citrate) is described as leading to an acute, measurable increase in total and ionized serum calcium levels (calcium in the blood). Due to this effect, official safety information describes the need for frequent monitoring of serum calcium levels for certain populations.


Q: Why do some people take Calcik even if they already have a high-calcium diet?

Individuals may choose Calcik to address specific absorption needs. The citrate form is recognized in scientific literature for maintaining good absorption even in environments with reduced stomach acid. This is often a relevant factor for populations like older adults, even if their dietary calcium intake is otherwise high.


Q: What happens if I stop taking Calcik suddenly?

Research has examined the effects of discontinuing calcium supplementation. Studies indicate that the beneficial effects on Bone Mineral Density (BMD) are generally not sustained after supplementation is stopped. Measured gains in BMD often diminish over one to two years once Calcik is discontinued.


Q: Is it normal to feel a mild upset stomach when first starting Calcik?

Gastrointestinal disturbances, including upset stomach, are described in official safety information as common side effects associated with Calcik (Calcium Citrate). If a common side effect like this occurs, regulatory documents describe the importance of monitoring symptoms and reporting any significant changes.


Q: Are there any known interactions between Calcik and hormonal birth control?

Official sources do not list a drug interaction between Calcik and hormonal birth control that affects the efficacy of either. However, medical literature notes that some types of oral contraceptives have been linked in studies to decreased bone density, a context in which calcium supplementation is often discussed for bone health maintenance.


Q: Is Calcik known to affect sleep or energy levels?

Research has explored the relationship between general calcium intake and sleep quality, suggesting a potential association where lower intake may be related to shorter sleep duration. This is a broad finding concerning total dietary intake, and official product information does not list specific effects on sleep or energy.


Q: How long does Calcik typically stay in the body after a dose?

While supplements generally do not have a standard half-life, the concentration of ionized calcium in the plasma (blood) is clinically tracked. Clinical pharmacology reviews describe that ionized calcium levels peak shortly after a dose, with the terminal elimination half-life estimated to be approximately two hours.


Q: How is Calcik different from the calcium found in dairy products?

Calcik is the citrate salt form of calcium, a synthetic organic salt. Calcium in dairy products is generally bound to phosphate or casein. The key difference is that the citrate form is recognized for being well-absorbed even when stomach acid production is reduced, making it a reliable option for specific absorption needs.


Q: Can Calcik be crushed or chewed if I have trouble swallowing pills?

The standard tablet form of Calcik is typically intended to be swallowed whole with water. Official guidelines only provide specific instructions for dissolving the effervescent (fizzing) form in water before ingestion. Regulatory documents do not provide instruction for crushing or chewing the standard tablet or capsule.


Q: Are there any common foods or drinks that should be avoided when taking Calcik?

Official information notes that the citrate component of Calcik may increase the absorption of aluminum. For individuals with reduced kidney function, official information notes that avoiding specific aluminum-containing products or foods/drinks high in citrate (like some citrus fruits) is a safety consideration.


Q: What is the likelihood of experiencing a severe side effect from Calcik?

Serious reactions, such as severe hypercalcaemia or hypersensitivity (allergic reaction), are addressed in safety information with urgent warnings, indicating they are medically significant risks. While specific frequency rates are not always published, the official safety profile describes the need for careful monitoring for signs of these serious risks.

How should Calcik be stored and disposed of?

Storage and Disposal Requirements

Official regulatory information defines specific conditions for storing and disposing of Calcik to maintain its stability and integrity.

Storage Conditions

Requirement Official Statement
Temperature Store in a refrigerator, typically between 2 C and 8 C (36 F and 46 F). Do not allow the product to freeze.
Handling Keep the medicine out of the sight and reach of children. Inspect the container visually before use; do not use if the solution is discolored or contains particles.
Stability Vials or ampoules are intended for single use only. Any remaining portion must be immediately discarded after administration. Diluted solutions prepared for infusion may have a limited in-use stability period, such as 8 to 24 hours, if prepared under aseptic conditions.

Disposal Rules

All unused Calcik and waste materials must be disposed of in accordance with local regulations for medicinal products. Disposal must be conducted by competent staff following established environmental and controlled-waste procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calcik found in:

A-Z Index: